ADVBNasdaqServices-Medical LaboratoriesFiscal year ends June 30
Advanced Biomed Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026
$4.16+0.18 (+4.52%)
Close on Oct 19, 2026
- Market cap
- $6.51M
- P/E (TTM)
- 0.8
- Dividend yield
- –
Share price
−$5.45 (−56.71%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Advanced Biomed Inc. reported revenue of $127.64K for fiscal 2026.
Revenue
$127.64K
FY2026
Operating income
-$6.23M
FY2026
EPS, diluted
$5.33
TTM Q4 2026
Key statistics
Valuation at the latest close; fundamentals over fiscal 2026, balances at Jun 30, 2026
Valuation
- Market cap
- $6.51M
- P/E ratio
- 0.8
- Price to sales
- 51.01
- Price to book
- 0.53
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $127.64K
- Net income
- $6.68M
- EPS, diluted
- $5.33
- Book value per share
- $7.84
- Diluted shares
- 2M
Four years at a glance
Fiscal years 2023 to 2026, USD
Revenue
$127.64K
Operating income
-$6.23M
Net income
$6.68M
EPS, diluted
$5.33
Free cash flow
–
Reported period